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Abstract: Trypanosomatid protozoa are unusual eukaryotes that are well known for having unusual
ways of controlling their gene expression. The lack of a refined mode of transcriptional control in
these organisms is compensated by several post-transcriptional control mechanisms, such as control
of mRNA turnover and selection of mRNA for translation, that may modulate protein synthesis
in response to several environmental conditions found in different hosts. In other eukaryotes,
selection of mRNA for translation is mediated by the complex eIF4F, a heterotrimeric protein complex
composed by the subunits eIF4E, eIF4G, and eIF4A, where the eIF4E binds to the 5′-cap structure
of mature mRNAs. In this review, we present and discuss the characteristics of six trypanosomatid
eIF4E homologs and their associated proteins that form multiple eIF4F complexes. The existence of
multiple eIF4F complexes in trypanosomatids evokes exquisite mechanisms for differential mRNA
recognition for translation.
Keywords: Kinetoplastids; eIF4E; translation initiation
1. Regulation of Gene Expression in Trypanosoma brucei and Related Trypanosomatids
Trypanosoma brucei and closely related organisms (collectively called trypanosomatids) are
uniflagellated parasitic protozoa belonging to the eukaryotic lineage Excavata and classified within
the order Kinetoplastida [1]. These organisms evolved from free-living phagotrophic protozoa (similar
to their current sister group, the Bodonids) into well-adapted parasitic organisms, having undergone
major changes that include serial loss of genes involved in macromolecular digestion and the assimilation
and multiplication of membrane transporters for scavenging metabolites from the host [2–4]. The family
Trypanosomatidae is composed, to date, of 19 genera of Monoxenous (one host, insect) and Dixenous
(two hosts, insect and vertebrate or plant) parasites [5]. Two of those, Trypanosoma and Leishmania, are
medically relevant, and have elicited substantial interest from the scientific community, due to their role
in diseases that affect millions of people. These diseases are found mainly in tropical and subtropical
areas of the world [6,7], and poignantly lack effective vaccines and means or proper control, with the
currently available treatments based on the administration of toxic drugs [8].
A number of unique features rarely seen in other eukaryotes characterize the basic biology of
trypanosomatids. An example is the peculiar way they control their gene expression, critical for their
adaptation to parasitic life in different hosts [9]. Little regulation of transcription is observed, with
their genes organized in clusters that are constantly transcribed into long polycistronic precursor
mRNAs [10,11]. Genes in the same cluster are typically functionally unrelated [12], and transcription
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initiation regions lack the usual RNA Pol II promoters, unlike other eukaryotes, but are controlled
epigenetically [13,14]. Following synthesis, the long transcripts are processed into mature mRNAs,
having individual coding sequences, by another unusual process called trans-splicing [15]. During
trans-splicing, the polycistronic precursor is cleaved, and a mini-exon spliced leader (SL) is added to
each monocistronic unit, defining the 5′ terminus of the mRNA. The subsequent polyadenylation of its
3′ end, in a manner reminiscent of other eukaryotes but dependent on different cis-acting elements,
defines the mature mRNA 3′ termini [16,17]. The SL trans-splicing process was first described in
trypanosomatids [18,19], and then later found to be present in many other eukaryotes, including
cnidarians, ctenophores, rotifers, platyhelminthes, nematodes, crustaceans, sponges, chaetognaths,
tunicates, dinoflagellates, and euglenids [20]. The conserved, 39 nt long, trypanosomatid mini-exon
is derived from a short precursor SL RNA transcript, a product of roughly 100–200 tandem SL RNA
genes [21]. The SL mini-exon is characterized by a highly modified 5′-cap structure, consisting of
the classical m7GTP (7-methylguanine) cap found at the 5′-end of eukaryotic mRNAs, followed
by modifications of the first four transcribed nucleotides of the SL sequence. These nucleotides
(AACU) are modified by the addition of 2′-O-methylations to all four ribose moieties, and by unusual
base-methylations found on the first adenine (m26A) and fourth uridine (m3U) [15,22]. The classical cap
plus the four modified nucleotides constitute the so called cap4 structure, unique to trypanosomatids
and involved in mRNA translation [23,24]. The m7GTP cap addition and modifications to the cap4
structure on the SL RNA occurs co-transcriptionally during the biogenesis of the SL precursor [25–27],
and are necessary for its efficient use during trans-splicing [28,29]. After maturation through proper
trans-splicing and polyadenylation, the protein coding mRNAs are exported to the cytoplasm, to be
recognized by the translation machinery [30].
Although the lack of traditional control for the trypanosomatid polycistronic transcription
suggests that adjacent genes would have the same levels of expression, it is known that, in fact,
many show strikingly different steady-state levels [11]. Additionally, a large fraction of the proteomes
of representative species exhibit changes according to their life stages, a likely consequence not only
of changes in mRNA and protein stability [31], but also in translation efficiency rates, selectively
targeting specific mRNAs that may play a significant role during the trypanosomatid complex life
cycle [32]. Hence, it is believed that control of gene expression in trypanosomatids is based on
mechanisms targeting post-transcriptional events, such as trans-splicing, mRNA transport, turnover,
and translation [9]. The present review details the knowledge acquired recently on mRNA translation
and its regulation in trypanosomatids through the study of the multiple homologues identified in these
organisms of the mRNA cap binding protein, also known as eIF4E. First, however, a brief overview on
the basics of the eukaryotic translation initiation and eIF4E is required.
2. The Eukaryotic Translation Initiation
Translation of mRNAs into proteins represents the ultimate goal of gene expression, essential
for the survival of all living organisms. As one of the most conserved cellular processes, it is
controlled by several protein factors that act upon four main stages: Initiation, Elongation, Termination,
and Recycling [33]. Translation regulation can be mediated by mechanisms acting at any of these
stages, but the main target is the Initiation stage, where a large number of accessory proteins, called
eukaryotic initiation factors (eIFs), are required. The eIFs participate in many critical steps required
for translation initiation to proceed, and these include the identification of mature transcripts, their
protection against nucleases, and recruitment to the ribosomes for the start of translation properly [33].
In summary, translation initiation begins with the assembly of the 43S “pre-initiation complex”
(PIC), composed of the Met-tRNAi, the tRNA carrying the anticodon for the first AUG, plus several
initiation factors (eIF1, eIF1A, eIF2, eIF3), and the small ribosomal subunit. The mature mRNA transcript
is recruited independently through the binding of the eIF4F complex to its 5′ end. The heterotrimeric
eIF4F complex is formed by the association of the eIF4E, eIF4G, and eIF4A subunits, where eIF4E is
responsible for the recognition and specific binding to the m7GTP cap found on the mRNA 5′ end. The
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43S PIC is driven to the mRNA 5′ end through an interaction between the multisubunit eIF3 complex,
and the eIF4G subunit of eIF4F. eIF4G also binds to both eIF4E and eIF4A, organizing the whole
eIF4F complex, while eIF4A is an RNA helicase responsible for unwinding any secondary structures
found in the mRNA’s 5′ untranslated region (5′ UTR). Simultaneously, the poly-A binding protein
(PABP) binds to the mRNA’s 3′ poly-A tail, and through its interaction with eIF4G, promotes the
mRNA circularization, leading to a closed-loop formation that enhances translation. The eIF4F helicase
activity facilitates the motility of the whole PIC along the mRNA, a requirement for the scanning of
the 5′ UTR, and the identification of the first AUG that defines the start of the open reading frame
(i.e., protein-coding region). Following AUG initiation, the eIF4F complex is released, followed by the
recruitment of the large ribosomal subunit, and subsequent formation of the first peptide bond of the
nascent protein (see [33–35] for a comprehensive review about the translation process).
eIF4E Family Members, Structure, and Function
The cap binding protein eIF4E is now recognized as representing a large eukaryotic protein
family, generally defined by the presence of up to eight conserved tryptophan/aromatic residues.
These were originally described based on the mammalian and yeast eIF4E homologs, with the
mammalian sequence numbering used as reference here: W43, W46, W56, W73, W102, W112,
W130, and W166. Four of these residues are essential for classical eIF4E functions, with W56,
W102, and W166 being required for cap recognition, while W73 is involved in eIF4G binding [36].
By comparing eIF4Es from a number of organisms, it was possible to determine that these tryptophan
residues are spaced within a conserved central region that is in agreement with the consensus
H(X5)W(X2)W(X8–12)W-(X9)F(X5)FW(X20)F(X7)W(X10)W(X9–12)W(X3435)W(X32–34). This central
region constitutes the typical eIF4E “core” found in all of this protein family members [37].
The eIF4Es fold into a “cupped-hand” tertiary structure, having eight antiparallel β-sheets and
three α-helices, that is critical for its ability to bind to the m7GTP cap [38]. Cap binding is mediated
by the two conserved tryptophans localized on eIF4E’s concave side, W56 and W102 (mammalian
eIF4E1 numbering), required to “capture” the mRNA cap through a pi–pi stacking interaction. Binding
interactions are also mediated through hydrogen bonds between E103 and the m7G cap, and by
electrostatic interactions between the positively charged residues R112, R157, and R162, with the
three phosphate groups of the m7GTP. A third tryptophan residue, W166, localized towards the
C-terminus of eIF4E is also involved in a specific interaction with the 7-methyl moiety of the cap
structure [39–42]. A network of hydrogen bonds also strengthen the eIF4E-cap interaction involving
the residues W56, D90, F94, W102, E103, R112, N155, R157, K162, W166, and H200 [43]. Through its
convex side, eIF4E may bind to several proteins with different roles, but its main partner in translation
is eIF4G [44,45]. The eIF4E–eIF4G binding is mediated by the VEDFW residues from eIF4E and the
canonical motif Y(X)4LΦ (where X represents any amino acid and Φ represents a hydrophobic residue)
localized within the N-terminal third of eIF4G [46]. This motif is also found in proteins, like the
well-known eIF4E-binding proteins (4E-BPs) [45], from several organisms that bind competitively
to eIF4E, preventing it binding to eIF4G, either to promote translation or the translational arrest of
specific mRNAs. A secondary non-canonical eIF4E binding motif within eIF4G, GLPHISDVVL in the
human protein, also acts in stabilizing the eIF4E–eIF4G binding, by interacting with the hydrophobic
residues F47, I63, L75, and I79 on the human eIF4E [47,48].
In higher eukaryotes, eIF4E is distributed mainly throughout the cytoplasm, although small
amounts are present in the nucleus, where it is distributed in discrete spherical bodies. In the nucleus,
eIF4E has been found to associate with the leucine rich pentatricopeptide repeat protein (LRPPRC),
as part of a specific protein–RNA complex, known as ribonucleoparticle (RNP). The LRPPRC protein
recognizes a ~50 nucleotide secondary structure element, called eIF4E sensitivity element (4E-SE),
found along the 3′UTR of selected transcripts. This complex also associates with the RNA helicase
UAP56 and with hnRNPA1 protein. Altogether the RNP acts in the export to the cytoplasm of
over 700 selected transcripts, transiting through the nuclear pore complex via the CRM1 export
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receptor [49,50]. In the cytoplasm, eIF4E is also found in different types of cytoplasmic bodies, known
as processing bodies (P-bodies) and stress granules (SG), that are respectively involved in mRNA
decay or storage [51–53].
The major role of eIF4E is in translation. Despite the overall conservation in the translation process
throughout the various eukaryotic lineages, several taxa have evolved unique mechanisms associated
with mRNA recognition and ribosome recruitment during the initiation of translation of specific sets of
mRNAs. These are reflected in a substantial variation in the number of eIF4E homologs among different
organisms. It is thought that during evolution, a single ancient eIF4E gene underwent a series of gene
duplications and modifications generating the families of related proteins seen in different eukaryotic
organisms. Not all eIF4E homologs necessarily act as translation initiation factors [36]. A phylogenetic
analysis made with eIF4E homologs from several organisms allowed their classification into three main
groups: eIF4E Class 1, represented by the prototypical eIF4E and having the eight typical tryptophan
residues, is able to bind to both the cap structure and eIF4G; eIF4E Class 2, represented by eIF4Es
with substitutions in residues equivalent to W43 and W56 for another aromatic residue, which are
involved in cap binding or 4E–BP interactions; and eIF4E Class 3, represented by proteins having
the W56 residue replaced by a C or Y, with no function clearly described [37]. The major diversity
of eukaryotic species, however, resides within protists, whose eIF4E homologs do not match this
classification. The eIF4E from protists are instead distributed in three distinct clades, with functional
data still limited to very few species [36].
Multiple eIF4E homologs and accessory proteins are, thus, commonly found in different
organisms performing distinct roles in translation [44,45,54,55]. For instance, initial data indicated that
mammalian eIF4E1 (Class 1) binds the cap, eIF4G homologs, and the 4E-BPs translation repressors,
while eIF4E2 (Class 2) binds only the cap and 4E-BPs. In contrast, eIF4E3 (Class 3) binds the cap,
eIF4G1 and eIF4G3 [53,56,57]. It has been thought for some time that eIF4E1 was the only eIF4E protein
involved in translation initiation in mammals, while eIF4E2 (formerly 4EHP) and eIF4E3 would be
involved in translation repression [58,59]. However, additional data indicated that mammalian eIF4E2
binds to eIF4G3 and translates a subset of mRNAs under hypoxic conditions [60], and that eIF4E3 is
active in translation under MNK-kinase dependent inhibition, ablating eIF4E1 phosphorylation and
promoting a unique translatome [61]. Hence, both eIF4E2 and eIF4E3 have roles in the translation of
subsets of mRNAs under specific situations, by forming alternative eIF4F complexes [62]. Specific
selection of mRNAs for different eIF4F complexes is also found in Caenorhabditis elegans, where five
eIF4E homologs (from Classes 1 and 2) are differentially expressed and recognize specific subsets of
mRNAs during the nematode development [63]. In plants, two eIF4F complexes, eIF4F and eIF(iso)4F
(both classified as Class 1), may have different translation efficiencies and preferences for distinct
mRNA subsets [64–66]. Bearing in mind the plethora of eIF4E functions that are associated with
the control of translation of functionally related mRNAs, and considering that in trypanosomatids,
subsets of mRNAs also seem to be grouped into post-transcriptional regulons with common regulatory
mechanisms [67], it is a sound hypothesis that multiple eIF4E homologs may play a significant role in
mRNA selection for translation as part of distinct eIF4F(-like) complexes (see Section 3 below).
3. eIF4E Homologs in Trypanosomatids and Protein Partners
Multiple homologs for the eIF4F subunits were identified in characterization studies involving
mainly Trypanosoma brucei and Leishmania species. There are six eIF4E, five eIF4G, and two eIF4A
homologs conserved in all trypanosomatid species investigated so far [68,69]. The eIF4E homologs
vary significantly in size and properties, and will be discussed in detail below. The eIF4Gs also vary
significantly in size and in the relative location of the conserved HEAT1/MIF4G domain, typical
of all eIF4G homologs. Based on sequence comparisons with better known metazoan and yeast
eIF4Gs, no clear motifs involved in the interactions with the eIF3 complex or with eIF4E and/or PABP
homologs can be found [69], although they are able to interact with other putative eIF4F subunits,
forming eIF4F(-like) complexes. For eIF4A, both homologs are important for cell survival, but only one
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is active during translation [70]. Additionally, there are two PABP homologs in T. brucei and three in
Leishmania that may be involved in the differential selection of mRNAs [71,72]. In the initial report for
the first trypanosomatid eIF4E, from L. major, the name LeishIF4E-1 was originally used [73]. However,
we rather follow and use here the recommended nomenclature for trypanosomatid proteins [74], where
the protein is named with a prefix representing the species abbreviation followed by the name of the
protein in upper case (e.g., LmEIF4E1, TbEIF4E1). Alternative terminology found in the literature
includes the protein name only and the species (e.g., L. major EIF4E1, T. brucei EIF4E1), or just the
protein name, when referring to the archetype properties shared by the orthologs (e.g., EIF4E1, referring
to both L. major and T. brucei).
The characterization of the first four eIF4E homologs in T. brucei classified them into two
groups, based on structural and molecular properties [75]. With the identification of two more
eIF4E homologs [68], however, a third group was proposed. Group 1 then is formed by EIF4E1 and
EIF4E2, relatively low abundant proteins with similar size and higher homology to the human eIF4E
homolog, that cannot form eIF4F-like complexes nor are required for general translation. The eIF4E
Group 2 is formed by EIF4E3 and EIF4E4, more abundant proteins having long N-terminal extensions
and lower overall homology within the eIF4E core, that however can form typical eIF4F complexes
implicated in general translation and essential for cell survival. Group 3 consists of EIF4E5 and EIF4E6,
very small proteins with low eIF4E core homology, but nevertheless, able to bind to eIF4G homologs as
part of novel eIF4F(-like) complexes unlikely to be involved in general translation [76]. As seems to be
the rule for the more divergent eIF4Es from protists, the trypanosomatid eIF4E groups do not fit into
the three previously defined eukaryotic eIF4E classes [37]. Nevertheless, further analysis comparing
only eIF4E sequences from various protist groups confirm that the EIF4E1–EIF4E2 and EIF4E3–EIF4E4
pairs belong to phylogenetically independent eIF4E clades [36], thus confirming their separation, based
on their biological properties, into two independent groups [75]. The detailed description of these three
trypanosomatid eIF4E groups will be considered now, taking into account the following parameters
commonly used to study eIF4E homologs: in silico structural properties, analysis of cap-binding
affinities, protein expression levels, binding partners and formation of eIF4F(-like) complexes, and
potential involvement during translation [77,78].
3.1. Trypanosomatid eIF4E Group 1: EIF4E1 and EIF4E2
The first reported eIF4E homolog from trypanosomatids, LmEIF4E1 (GeneDB ID#: LmjF.27.1620),
was characterized from L. major and described as a 214 aa protein (23.84 kDa) with 42% similarity
to mammalian eIF4E. Its predicted 3D structure, modeled using alternatively the GenTHREADER
and Modeller programs or the SwissPDBViewer, indicated that it should fold into a structure overall
compatible to the one described for the mammalian eIF4E, despite the low conservation in sequence
between the two proteins. Exceptions are the two short insertions inside the eIF4E core region, that
could not be modeled, and the lack of the C-terminus found in both mouse and yeast homologs [69,73].
These initial reports emphasized the main features of LmEIF4E1, where the conservation of seven out
of the eight characteristic tryptophan residues typical of eIF4E family members [40,57] was observed,
including those involved in cap binding: W37, W93, and W176 (equivalents to W56, W102, and W166
in mammals). The single exception was the F54 residue replacing the equivalent W73 position of
mammalian eIF4E, involved in the interaction with eIF4G. Counterparts to several other residues
involved in known eIF4E interactions (such as E103, R112, R157, and K162 in the mammalian protein)
were also found in LmEIF4E1 (E84, K93, R167, and K172) [69,73]. TbEIF4E1, the T. brucei EIF4E1
ortholog (GeneDB ID#: Tb927.11.2260) was later characterized as a 233 amino acid polypeptide
(26.02 kDa) with characteristics conserved with the Leishmania protein, and also having seven out of
the eight conserved tryptophan residues, with a phenylalanine replacing W73 [75].
LmEIF4E2 (GeneDB ID#: LmjF19.1500/LmfF19.1480) is a 281 aa protein (31.46 kDa) with 41%
similarity to the human homolog and whose gene is found in two copies within the L. major genome.
This protein has all conserved tryptophan residues typical of eIF4E homologs, including those
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equivalent to W56, W102, and W166 in the human protein involved in cap binding (W45, W91,
and W173 in LmEIF4E2), as well as positively charged residues required to bind to the phosphate
groups of the m7GTP (K101, R152, and K169). Noteworthy is the replacement of a highly conserved
aspartate in eIF4E sequences, D104 in the human protein, for a histidine (W93). LmEIF4E2 is also
characterized by the presence of short insertions localized within the eIF4E core region, next to
amino acids relevant to cap binding, and a much larger insertion closer to its C terminus, but its 3D
structure was also compatible with mammalian eIF4E [69,79]. Its T. brucei ortholog, TbEIF4E2 (GeneDB
ID#:Tb927.10.16070), is a 251 aa protein (28.3 kDa) with features similar to those found in LmEIF4E2,
but with changes the insertions found within the LmEIF4E2 core and lacking C-terminal extension
entirely [75]. A schematic representation of the two sets of EIF4E1 and EIF4E2 homologs described
here can be seen in Figure 1, with relevant sequence motifs in common highlighted.
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Figure 1. Schematic representation of EIF4E1 and EIF4E2 homologs from T. brucei and L. major.
The eIF4E core regions are represented in grey; black boxes represent insertions within these core
regions; tryptophan residues involved in cap binding are highlighted in blue; residues involved in
eIF4G-binding are highlighted in red. The E-value numbers and the domain boundaries were generated
through sequence searches using the on line tool Pfam Database [80,81].
3.1.1. EIF4E1 and EIF4E2 Subcellular Distribution and Abundance
Early cell fractionation assays, analyzed by Western blotting, determined that both LmEIF4E1 and
LmEIF4E2 were found mainly in cytoplasmic fractions [73,79]. Later, indirect immunofluorescence using
specific antibodies for the native proteins, and direct visualization of ectopically expressed fluorescent
TbEIF4E1 and TbEIF4E2, fused to EYFP, indicated that they can be found in both the cytoplasm and
nucleus, at least in T. brucei procyclic cells [75,82]. Under standard growth conditions, TbEIF4E1 was
also seen to partially localize to cytoplasmic granules and under nutritional deprivation and sinefungin
treatment; a large fraction co-localized with the stress granule marker DHH1 within granules localized
in t e nuclear periphery and within sinefungin-induced p-bodies, exhibiting a behavior similar to that
found for PABP2. In the case of TbEIF4E2, only a minor pres nce was detected in starvation stress
granules [72]. More recent data, derived f om the whole proteome tagging project for the fluorescence
localization o T. brucei proteins, indicate that TbEIF4E1 i found mainly in the cytoplasm, within
various speckles, with no apparent presence in the nucleus (data available at Tryptag [83]).
Expres ion analysi by Western blotting in promastigote cell extracts have shown that LmEIF4E1
is not an abundant protein, found in roughly 2 to 4 × 103 molecules/cell in Leishmania [69] and 3 to
8 × 103 molecules/cell in T. brucei procyclic form and 1.5–5 × 103 molecules/cell for b oodstream
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form [75]. In L. amazonensis, Western blotting assays using cell extracts from promastigotes and
amastigote-like forms indicated that LaEIF4E1 is expressed more in amastigotes [79]. This higher
expression was postulated to be due to an element found within the 3′UTR of the LmEIF4E1 mRNA
that is similar to the regulatory element found in the Leishmania amastin messenger, and is involved in
amastigote-specific expression [79,84]. LmEIF4E2 is also not abundant, detected at about 103 molecules
per cell in Leishmania [69] and between 1 to 5 × 103 molecules/cell in both forms of T. brucei [75].
Microarray analysis has detected LmEIF4E2 within a subset of genes expressed preferentially in
metacyclic form of L. major [85], but to date, this has not been confirmed by protein expression analysis.
3.1.2. EIF4E1 and EIF4E2 Cap Binding Affinities
Cap binding affinity assays have shown that recombinant LmEIF4E1 is able to bind to
7mGTP Sepharose 4B beads, and can be specifically eluted with soluble m7GTP. Additionally,
time-synchronized fluorescence titration assays have shown that LmEIF4E1 is able to bind to both cap4
and m7GTP, in contrast to mouse eIF4E1, which has lower affinity to cap4 than to m7GTP [69,73,79].
Its T. brucei ortholog, TbEIF4E1, was only tested with the m7GTP resin, but its binding to the beads was
very similar to what was seen with LmEIF4E1 [75]. In contrast, LmEIF4E2 failed to bind efficiently to
the m7GTP beads [69], even though it has all residues required for such interaction, and the fluorescence
titration assay revealed that it has a much greater affinity to cap4 when compared with m7GTP and
other cap analogs [79]. TbEIF4E2 differs markedly from its Leishmania ortholog in that it was able to
bind efficiently to the m7GTP beads, a difference that might be due to structural differences associated
with the unique LmEIF4E2 insertion seen next to its C-terminus [75].
3.1.3. EIF4E1 and EIF4E2 Partners and Possible Roles in Translation
When Leishmania whole-cell lysates were loaded onto m7GTP-Sepharose columns, and specifically
bound proteins eluted with soluble cap analogue, LmEIF4E1, LmEIF4E4, LmEIF4G3, and LmEIF4AI were
found in the eluted fraction. This was interpreted as both eIF4E homologs were able to interact with
LmEIF4G3 and LmEIF4AI, and indeed, GST pull-down assays seemed to confirm an interaction between
LmEIF4G3. Also, LmEIF4E4, LmEIF4A1 and a small amount of LmEIF4E1 came down with the eIF4G
homolog when a FLAG-tagged LmEIF4G3 was specifically precipitated. Polysomal fractionation analysis
using sucrose gradients identified both LmEIF4E1 and LmEIF4E4 in heavier fractions co-migrating with
LmEIF4G3 in lysates made from regular promastigotes grown at 26 ◦C, but the polysomal presence
of LmEIF4E4 decreased in lysates made with parasites exposed to elevated temperatures, therefore
mimicking vertebrate host conditions, while LmEIF4E1 could still be detected in the same fractions. These
results led to the conclusion that the LmEIF4E1–LmEIF4G3 complex could be active in translation in both
parasite life stages [86]. However, follow up mass spectrometry and yeast two-hybrid assays refuted
the interaction between LmEIF4E1 and LmEIF4G3, and between LmEIF4E1 and any of the remaining
Leishmania eIF4G homologues [87]. Subsequent in vitro pull-down assays also failed to confirm the
interaction between recombinant LmEIF4E4 and LmEIF4E1, and in T. brucei, in vitro and in vivo assays
confirmed that LmEIF4E4 is the true and only LmEIF4G3 eIF4E partner [75,88]. The Leishmania mass
spectrometry data, however, did identify a novel EIF4E1 partner, called 4E-interacting protein (4E-IP). This
is a mostly unstructured protein lacking homologs outside the trypanosomatids, but that seems to interact
with EIF4E1 through a canonical eIF4E binding motif, YTREELL [87]. 4E-IP is constitutively expressed
in Leishmania [89], but its interaction with EIF4E1 seems to be restricted to the promastigote stage of the
parasite life-cycle, since it was not detected in L. amazonensis amastigote-like forms [87]. More recently,
it was reported that LmEIF4E1 interacts directly with the Leishmania translation initiation complex eIF3,
through the C-terminus region of the EIF3a subunit, indicating a role in translation independent of any
eIF4G function [90]. In T. brucei TbEIF4E1, and also TbEIF4E2, knockdown assays in procyclic cells did not
show any particular effect on cell growth/viability or any effect in translation, but TbEIF4E1 knockdown
in bloodstream cells did lead to a decrease in cell growth, but without compromising cell viability, while
TbEIF4E2 knockdown did not cause any apparent growth effect [75]. High throughput RNAi assays have
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shown only abnormal cell growth in late bloodstream form for both proteins [91]. In contrast, double
knockdown of TbEIF4E1 and TbEIF4E2 leads to a rapid cell death in procyclic cells, with no significant
effect on translation, while double knockdown of TbEIF4E1 and TbEIF4E4 leads to cell growth arrest
with a major reduction in translation, but no immediate cell death [75]. A major breakthrough in sorting
the TbEIF4E1 function came from a screening using a tethering assay aimed at identifying potential
activators and repressors of mRNA translation. Both TbEIF4E1 and the Tb4E-IP ortholog were seen to
efficiently suppress the expression of a reporter mRNA when tethered to its 3′UTR, indicating a role for
both proteins in translation repression [92,93]. Figure 2 summarizes the data available so far regarding
EIF4E1 function in trypanosomatids, with potential roles in both translation stimulation and repression.
Much less is known about EIF4E2, however, our unpublished work indicates a strong physical association
of TbEIF4E2 with the histone mRNA stem-loop binding protein.
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Figure 2. Summary of the complexes formed EIF4E1 and EIF4E2. Available data indicates that EIF4E1
might be involved in translation repression when bound to 4E-IP, and translation stimulation when
bound to EIF3 complex through EIF3a subunit interaction. EIF4E2 interaction with its specific partner
and their biological function still needs to be addressed.
3.2. The Trypanosomatid eIF4E Group 2: EIF4E3 and EIF4E4
LmEIF4E3 (GeneDB ID#: LmjF.28.2500) is a 349 aa protein (38.0 kDa) with 43% similarity to
human homologs, having only four of the conserved tryptophan residues typical of eIF4E sequences.
These include the residues equivalent to W102 and W166, involved in cap binding (W216 and W286 in
LmEIF4E3), and the equivalent to the mammalian W73 residue involved in binding to eIF4G (W187 in
LmEIF4E3). The third tryptophan involved in cap recognition, W56, is replaced by a phenylalanine
(F172), but several positively charged a ino acids are also found near to positions equivalent to R112,
R157, and K162 in human eIF4E. As for EIF4E2 sequenc s, the near universal aspartate at position
104 in the mammalian eIF4E, next to or within the cap binding pocket, is eplaced by a histidine in
LmEIF4E3 (H218) and in other Leishmania EIF4E3 orthologs. TbEIF4E3 (Ge eDB ID#: Tb927.1 .11770)
is a 442 aa protein (47.96 kDa) also having four conserved tryptophan residues at equivalent positions
as well as similar positively charged amino acids and the D104 replacement. The feature common
to the various EIF4E3 sequences, which distinguish them from other eIF4Es, is their long N-terminal
extension, also found in EIF4E4 homologs (see below) [69,75,94].
LmEIF4E4 (GeneDB ID#: LmjF.30.0450) is a 447 aa protein (48.0 kDa) having 45% similarity to the
human homolog. Five of the conserved tryptophan residues typical of eIF4Es are present including
those equiv lent to both W102 and W166 (W330 and W391 in LmEIF4E4), involved in cap recog ition,
and the W73 residue equired for the eIF4G int raction (W302). As for LmEIF4E3, the th rd cap-interacting
tryptophan in humans, W56, is replaced by another aromatic residue in LmEIF4E4 (a tyrosine, Y287),
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but positively charged amino acids required to stabilized the cap interaction are generally also present [69].
TbEIF4E4 (GeneDB ID#: Tb927.6.1870) is a 427 aa protein (46.54 kDa) also having the same five conserved
tryptophan residues and related residues in the positions described above [75]. Additionally, similar to
LmEIF4E3, long N-terminal extensions are also present in all trypanosomatid EIF4E4 orthologs, although
little homology in sequence is observed between the EIF4E3 and EIF4E4 extensions [69,75,94]. Major
sequence features for both sets of EIF4E3 and EIF4E4 homologs are represented in Figure 3.
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The eIF4E core regions are represented in grey; insertions within these core regions are represented
by black boxes; tryptophan residues involved in cap binding are highlighted in blue; and residues
involved in eIF4G-binding are highlighted in red. The Boxes 1, 2 and 3 represent three conserved
regions likely involved in binding to PABP homologs and localized within the N-terminal extensions
of EIF4E3 and EIF4E4. The E-value numbers and the domain boundaries were generated through
sequence searches using the on line tool Pfam Database [80,81].
3.2.1. EIF4E3 and EIF4E4 Subcellular Distributions and Abundance
Cell fractionation assays were lso used for the preliminary definition of the LmEIF4E3 and
LmEIF4E4 subcellular localization, and both wer found to be present exclusively in th ytoplasm in
promastigotes [79]. This was co firmed for the T. brucei orthologs using immunofluorescence with
polyclonal serum directed again t the two native proteins, as well as direct fluoresc nc assays using
EYFP tagging in procyclic cells [75,82]. The same localization was seen for their respective eIF4G
partners, TbEIF4G4 and TbEIF4G3 [88] (see below). Results from the whole proteome fluorescence
tagging project confirmed the conspicuous cytoplasmic localization of TbEIF4E3 with no granular
formation under standard growth conditions [83]. Further immunolocalization experiments in
Leishmania, however, revealed that under starvation conditions, LmEIF4E3 migrated to cytoplasmic
granules that apparently lacked its partner LmEIF4G4. Based on these and other results, a hypothesis
has been proposed that LmEIF4E3 is inactive under optimal growth conditions when bound to
LmEIF4G4, but upon phosphorylation, under nutrient deprivation, dissociates from LmEIF4G4 and
enters stress granules where inactive mRNAs are stored [95]. This hypothesis, however, is not
supported by the data from T. brucei, where TbEIF4E3 exhibited only minor localization to stress
granules, a pattern also seen for TbEIF4E4, TbEIF4G3, and TbPABP1 [72].
The quantification of the EIF4E3 expression has shown that it is the most abundant of the
eIF4E homologs in trypanosomatids, with its abundance estimated to range within 2 × 104 and 105
molecules/cell for Leishmania promastigotes, as well as both procyclic and bloodstream life forms of
Pathogens 2017, 6, 55 10 of 25
T. brucei. EIF4E4, with its abundance quantified only in T. brucei, was found to be the second most
abundant eIF4E homolog, ranging from 2 to 4 × 104 and 1 to 2 × 104 molecules/cell in procyclic and
bloodstream forms, respectively [69,75].
3.2.2. EIF4E3 and EIF4E4 Cap Binding Affinities
Cap binding assays using 7methyl-GTP Sepharose 4B beads determined that neither LmEIF4E3
nor TbEIF4E3 were able to bind to the monomethylated cap structure found in m7GTP-Sepharose
beads [69,75]. Time-synchronized fluorescent titration assays, however, established that LmEIF4E3 is
able to bind to the m7GTP, and that its affinity is significantly higher than to the cap4 analogues [79].
In contrast, LmEIF4E4 was found to have the highest affinity to both m7GTP and cap4 analogues among
the various trypanosomatid eIF4Es [68,79,96]. Indeed, m7GTP-Sepharose beads were used to efficiently
purify native LmEIF4E4 from whole soluble Leishmania cytoplasmic fractions [86], the recombinant
protein from bacterial extracts [79], and the 35S-labelled LmEIF4E4 after in vitro translation in the
rabbit reticulocyte system [75]. Cap binding analysis by TbEIF4E4 also confirmed a similar affinity
to m7GTP-Sepharose beads as found in LmEIF4E4 [75]. Altogether, the data collected indicate that
EIF4E4 has a cap binding affinity substantially higher than EIF4E3.
3.2.3. EIF4E3 and EIF4E4 Partners and Binding Interactions
The first trypanosomatid eIF4F-like complex was defined after the purification of both LmEIF4E4
and LmEIF4G3 from whole Leishmania cell lysates using m7GTP-Sepharose beads, followed by the
confirmation that LmEIF4G3 is a true LmEIF4E4 partner through co-precipitation assays [86]. Mass
spectrometry analysis of tagged LmEIF4E4 purified from lysates of L. major promastigotes confirmed that
the complex LmEIF4E4–LmEIF4G3–LmEIF4AI occurs in vivo, and co-precipitates with LmPABP1 and
LmPABP2, plus several eIFs and ribosomal proteins, reinforcing the model that LmEIF4E4 is part of a
functional translation initiation complex acting in cooperation with LmEIF4G3, LmEIF4AI, and PABP
homologs [87]. The interaction between EIF4E4–EIF4G3 homologs was also confirmed in T. brucei through
pull-downs and immunoprecipitation assays, where tagged TbEIF4E4 brought down TbEIF4G3 and
TbEIF4AI. The same report also defined a second trypanosomatid eIF4F complex through the identification
of TbEIF4G4 as the TbEIF4E3 functional partner, both proteins co-precipitating with TbEIF4AI [75].
The direct binding between LmEIF4E4 and LmEIF4G3 was initially confirmed using the yeast
two-hybrid system and found to require the motif YPGFSLD (critical residues for eIF4E binding are
highlighted), localized within the short LmEIF4G3 N-terminus [86]. Independent pull-down assays found
that although the replacement of the FSL residues (F23/S24/L25) for three alanines caused ablation of
the LmEIF4E4–LmEIF4G3 interaction, additional substitutions nearer to the LmEIF4G3 N-terminus and
targeting two neighboring isoleucine and arginine residues (I8/R9) also prevented this interaction [88].
Within EIF4E4, additional yeast two-hybrid experiments have identified the LmEIF4E4 W302 (originally
reported as W163 due to a genome annotation error) as critical for LmEIF4G3 binding [87]. The direct
LmEIF4E3–LmEIF4G4 interaction was also confirmed through yeast two-hybrid assays and mass
spectrometry analysis of proteins co-precipitated with tagged LaEIF4E3 and LaEIF4G4 in L. amazonensis,
the two proteins likely forming a complex with LmEIF4A1 and LmPABP2. The EIF4E3–EIF4G4 interaction
was seen to require the W187 from LmEIF4E3, and the conserved leucine L26 in LmEIF4G4 [95]. Further
pull-down assays revealed that the LmEIF4E3 binding site in LmEIF4G4 indeed involves L26 plus the
neighboring I25. Both residues align with I8/R9 from LmEIF4G3, and may form part of a divergent eIF4E
binding motif, related to but distinct from the proposed consensus described within eIF4G homologs
from higher eukaryotes (YXXXXLΦ—X meaning any amino acid residue, while Φ indicates a long-chain
hydrophobic residue such as L, M, or F [56]). The F23/S24/L25 residues from LmEIF4G3 also implicated
in its binding to LmEIF4E4 align with an equivalent motif in LmEIF4G4 as well (F23/S24/L25), however,
their replacement for three consecutive alanines does not impact on the EIF4E3–EIF4G4 interaction [88].
Through the study of their eIF4G partners, vital aspects of the trypanosomatid eIF4E functions
have been clarified. Both LmEIF4G3 and LmEIF4G4 were found to be capable of binding to EIF4AI,
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the only eIF4A homolog implicated in translation initiation in trypanosomatids [70]. This interaction
is mediated by the eIF4G HEAT1-MIF4G domain, and requires the conserved L67/N68/K69 motif
(LmEIF4G3 numbering). The HEAT1-MIF4G domain from LmEIF4G3 binds to LmEIF4AI on its own,
but for LmEIF4G4, this interaction requires the full-length protein [94]. LmEIF4G3 can also interact
with LmPABP1 in vitro, and specifically co-precipitates with native LmPABP1, but not with LmPABP2
nor LmPABP3 [71,88]. The direct LmEIF4G3–LmPABP1 interaction, however, could not be confirmed
by yeast two-hybrid assays [87]. Surprisingly, subsequent yeast two-hybrid experiments reported
a new specific interaction between LmEIF4E4 and LmPABP1, involving the LmEIF4E4 N-terminal
extension [87]. This unique EIF4E4–PABP1 interaction in L. infantum was later defined to be dependent
on three conserved motifs that fit the consensus L/MN/DXXAXXY/FXP localized at the N-terminus
of EIF4E4, and it is essential for cell viability [94] (the three conserved consensus sequences or boxes
are represented in Figure 4 below labeled as B1, B2, and B3). The consensus that emerges then is
that the EIF4E4–EIF4G3 based complex is tightly associated with PABP1, and these proteins have
common roles in translation. At this stage, however, it is not clear if a similar association exists between
the second eIF4F-like complex, EIF4E3–EIF4G4, and PABP2. Figure 4 summarizes the data available
regarding the two eIF4F-like complexes based on EIF4E3 and EIF4E4 and their binding partners.
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Figure 4. Summary of eIF4F complexes formed by EIF4E4 or EIF4E3 and their respective partners. EIF4E4
forms the main eIF4F complex in trypanosomatids involved in translation by interacting with EIF4G3
(which also binds to EIF4A1), and to PABP1 through three small regions (Boxes B1, B2 and B3) at its
N-terminal extension which bind to the PABPC domain of PABP1. Similar composition might perhaps be
found on the secondary eIF4F complex formed by EIF4E3 with EIF4G4, EIF4A1 and a PABP homologue.
3.2.4. EIF4E3 and EIF4E4 Roles in Translation
So far, among all trypanosomatid eIF4E homologs, only EIF4E3 and EIF4E4 have been implicated
as having direct roles in translatio . Early sucrose gradient an lysis had already shown that both
LmEIF4E3 and LmEIF4E4 were present in olysomes [79,86], a result corroborated by more recent data
that has found LmEIF4G3, the EIF4E4 partner, interacti g d rectly with th multisubunit eIF3 complex,
therefore highlighting the role of the LmEIF4E4–LmEIF4G3–LmEIF4AI–LmPABP1 assembly as a
participant in translation initiation [90,97,98]. For EIF4E3, however, conflicting results were derived
from L. amazonensis, where it was not found associated with the polysomal fractions, but instead,
was found mainly in the top fractions of the gradient [95]. In contrast, in T. brucei, both TbEIF4E3
and TbEIF4E4 and their corresponding partners, TbEIF4G4 and TbEIF4G3, as well as TbEIF4AI, were
detected in free and membrane-bound polysomes, with TbEIF4E4 the most abundant in polysomes [99].
In agreement, the tethering screen performed in T. brucei to search for activators and repressors of
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mRNA translation defined both TbEIF4E3 and TbEIF4E4 as well as their partners, TbEIF4G4 and
TbEIF4G3, and the two PABP homologs (TbPABP1 and TbPABP2) as activators capable of enhancing
the translation of a reporter mRNA when tethered to its 3′UTR [92,93].
The implications for a role in translation for both EIF4E3 and EIF4E4 are reinforced by the results
derived from RNAi in experiments in T. brucei. Induced, RNAi based, TbEIF4E3 knockdown leads
to cell death in both procyclic and bloodstream forms of T. brucei, with an apparent direct effect in
translation, at least in procyclic cells [75]. A similar lethal effect was also found for TbEIF4G4 after
depletion in procyclic cells, but in contrast to its partner, this was not associated with significant
decreases in protein synthesis [88]. These results were independently confirmed by high throughput
RNAi experiments, where loss of either TbEIF4E3 or TbEIF4G4 led to significant loss of fitness in
procyclic, bloodstream, and differentiation stages of T. brucei [91]. In contrast, TbEIF4E4 knockdown
prevents viability only in bloodstream forms, although a nearly complete arrest in translation and
growth, without cell death, is observed when both TbEIF4E4 and TbEIF4E1 are simultaneously depleted
in procyclics [75]. The data for TbEIF4G3 is more robust, since its depletion in procyclic forms leads to
a very rapid arrest in protein synthesis, without apparent morphological implications and preceding
cell death [88]. Interestingly, in the independent high throughput RNAi experiments, depletion of
TbEIF4E4 leads to reduced growth in late bloodstream stage and mainly affected differentiating cells,
while TbEIF4G3 depletion produced no effect [91]. Regardless of the lack of RNAi effect in T. brucei
procyclic cells, the EIF4E4 gene cannot be deleted in L. infantum, and complementation assays have shown
that the LiEIF4E4–LiPABP1 binding is required for LiEIF4E4 function and cell viability. Cells having a
mutant LiEIF4E4 unable to interact to LiEIF4G3 as the sole LiEIF4E4 source were viable, but could not
differentiate to amastigotes [94]. Another implication for the importance of TbEIF4E4 function during
differentiation was the RNA-dependent association of TbEIF4E4 with PTP-tagged ALBA2 and ALBA3 in
T. brucei [100]. ALBA proteins are involved in several cellular processes that include genome packaging
and organization as well as transcriptional and translational regulation [101]. Downregulation of ALBA3
and ALBA4 is apparently involved in trypanosome development and differentiation from mesocyclic
trypomastigotes to the epimastigote stage in the anterior midgut of tsetse fly [102]. Remarkably, double
RNAi of the ALBA3/ALBA4 proteins produced a cell growth arrest similar to the one observed for the
TbEIF4E1/TbEIF4E4 double RNAi, also leading to a morphologically similar, elongated cells [75,102].
3.2.5. EIF4E3 and EIF4E4 Phosphorylation
In L. amazonensis, under conditions of nutrient depletion emulating the environment inside
the insect midgut, EIF4E3 has been shown to undergo hyperphosphorylation, with a likely impact
on the LaEIF4E3–LaEIF4G4 interaction. In vitro differentiation assays have also shown that in
axenic amastigotes, LaEIF4E3 undergoes hyperphosphorylation, and the LaEIF4G4 abundance was
significantly reduced [95]. Multiple phosphorylation events targeting EIF4E3 and EIF4E4 were
independently detected in both Leishmania and Trypanosoma species, and found to be mainly directed to
their N-terminal extensions [94,103–105]. L. amazonensis expression analyses have shown that although
LaEIF4E3 and LaEIF4E4 are constantly expressed during different growth phases, they show opposite
phosphorylation patterns when log and stationary phase of growth cultures are compared. LaEIF4E3
seems to be preferentially phosphorylated early after passaging and during late, stationary phase
growth. In contrast, multiple phosphorylated isoforms of LaEIF4E4 predominate during exponential
growth, coinciding with active protein synthesis. This pattern of phosphorylation is conserved in
T. brucei for TbEIF4E4, but not for TbEIF4E3 [103]. Similar results for LiEIF4E4 were also seen in
L. infantum where phosphorylated LiEIF4E4 was present during active growth of both promastigotes
and differentiated amastigotes, while the dephosphorylated LiEIF4E4 appeared in late stationary
phase culture in both life stages. Through mutagenesis analysis, the LiEIF4E4 phosphorylation
was studied further and found to be directed to multiple serine or threonine residues, followed
by a proline (SP or TP motifs), a pattern of phosphorylation associated with MAP-like or CDK-like
kinases. Contrary to what is seen in mammals, where the eIF4E kinase, Mnk, binds to eIF4G in
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order to phosphorylate eIF4E, the phosphorylation of LiEIF4E4 is not dependent on its interaction
with LiEIF4G3. An LiEIF4E4 mutant missing most of the phosphorylation sites, however, can still be
functional and replace the wild type protein in complementation assays [94]. More recently, in T. brucei,
TbEIF4E4 and its TbPABP1 partner have been found to be phosphorylated by CRK1, a CDK kinase
involved in controlling the G1/S transition [106].
3.3. The Trypanosomatid eIF4E Group 3: EIF4E5 and EIF4E6
EIF4E5 and EIF4E6 are the least studied and the more recently described of the trypanosomatid
eIF4Es, having very limited sequence homology to other eIF4E homologs. In L. major, LmEIF4E5
(GeneDB ID#: LmjF.36.0590) is a small, 219 aa (23.9 kDa) protein having only four of the typically
conserved tryptophan residues, including two equivalent to the mammalian eIF4E W56 and W166
involved in cap binding and recognition (W33 and W156 in LmEIF4E5, respectively) and the equivalent
to the W73 implicated in eIF4G binding (W58). The third cap binding residue, W102 in mammalian
eIF4E, is replaced by a conserved aromatic substitution (Y88). The T. brucei TbEIF4E5 ortholog (GeneDB
ID#: Tb927.10.5020) is a 195 aa protein (21.9 kDa) also having the same four conserved tryptophan
residues, and the aromatic substitution for the mammalian W102. Both proteins also have several
positively charged residues at the positions required for the stabilization of the cap interaction [68].
The EIF4E6 proteins are the smallest of the eIF4E homologs, with the 182 aa LmEIF4E6
(20.28 kDa—GeneDB ID#: LmjF.26.0240) having only two conserved tryptophan residues, including the
one equivalent to W166 (W150 in LmEIF4E6), as well as conserved aromatic substitutions replacing the
W56 and W102 cap-interacting residues (Y36 and F82), and the W73 involved in the eIF4G interaction
(Y53). Its T. brucei ortholog, TbEIF4E6 (GeneDB ID#: Tb927.7.1670), is a 186 aa (20.86 kDa) protein
having the same conserved tryptophan residues seen for its L. major counterpart, as well as aromatic
substitutions replacing the W56 and W102 mammalian residues (F29 and F80). Noteworthy, however,
is the lack of an aromatic residue at the W73 position, replaced by a histidine (H51) in TbEIF4E6. As for
EIF4E5, both L. major and T. brucei EIF4E6 orthologs also have positively charged arginine and lysine
residues in the positions required to stabilize the cap interaction [96]. Sequence features for both sets
of EIF4E5 and EIF4E6 homologs are represented in Figure 5.
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Figure 5. Schematic model of EIF4E5 and EIF4E6 homologues from T. brucei and L. major. eIF4E core
region is represented in grey rectangle; Insertions inside the core region of EIF4E5 and EIF4E6 are
represented in black boxes; Tryptophan residues involved in cap binding are highlighted in blue;
Residues involved (or equivalent) in eIF4G-binding are highlighted in red. The E-value numbers
and the domain boundaries were generated through sequence searches using the on line tool Pfam
Database [80,81].
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3.3.1. EIF4E5 and EIF4E6 Subcellular Distributions, Abundance, and Cap Binding Affinities
With the lack of efficient antibodies to evaluate its expression, the cellular distribution of TbEIF4E5
was determined through immunofluorescence against using a PTP-tagged protein. Localization was
found to be diffuse, throughout the cytoplasm, with numerous foci of greater intensity [68], similar
to what was found for TbEIF4E3 and TbEIF4E4 [75,82]. Using a similar approach, TbEIF4E6 was
also found as a cytoplasmic protein absent from the nucleus [96]. The results for both proteins are in
agreement with the data from the whole proteome fluorescence tagging project [83].
No precise quantitative data for the abundance of EIF4E5 or EIF4E6 is available to date,
but preliminary analysis revealed that both are the least expressed of the eIF4E homologues in the insect
forms from both L. major and T. brucei (our group unpublished data). According to a high throughput
proteomic expression analysis, LmEIF4E5 is constitutively expressed in L. major promastigotes and in
lesion derived amastigote [89]. Despite their sizes, both EIF4E5 and EIF4E6 have structural features
typical of cap-interacting proteins. To evaluate their cap binding affinities, they were also tested using
fluorescence-titration curves with four different cap analogs. Recombinant TbEIF4E5 was found to
bind to both m7GTP and cap4 with equivalent affinities to both analogs [68], falling within the range
of other L. major eIF4Es [79]. TbEIF4E6 was also tested using the same assay, and it also binds similarly
to both m7GTP and cap4, although with overall affinities lower than TbEIF4E5 [96].
3.3.2. EIF4E5 Binding Partners
The search for putative TbEIF4E5 and TbEIF4E6 partners started with a yeast two-hybrid
experiment designed to evaluate possible interactions with any of the five known trypanosomatid
eIF4Gs from T. brucei. For TbEIF4E5, these assays revealed that it interacted specifically with two
eIF4G homologs, TbEIF4G1 and TbEIF4G2, but with none of the other eIF4Gs tested. The binding was
specific for TbEIF4E5, since neither of the two eIF4G homologs was able to interact with the remaining
trypanosomatid eIF4Es. TbEIF4E5 binding to TbEIF4G2 seemed to be stronger than to TbEIF4G1,
but the assay was not appropriate to evaluate quantitative differences. Mass spectrometry analysis with
purified tagged TbEIF4E5 confirmed the TbEIF4E5–TbEIF4G1 and TbEIF4E5–TbEIF4G2 interactions
in vivo. Tagging and purification of both eIF4Gs revealed the presence of TbEIF4E5 in two independent
sub-complexes, each with a different eIF4G homolog. The first complex is formed by TbEIF4E5,
TbEIF4G1, a homolog for the protein known as 14-3-3 (Tb927.11.68710), and two hypothetical proteins
Tb927.11.6720 (117.5 kDa) and Tb927.11.350 (47.5 kDa). The second complex is formed by TbEIF4E5,
TbEIF4G2, two distinct 14-3-3 homologs (Tb927.11.9530 and Tb927.11.68710, named Tb14-3-3 I and
II), and yet another hypothetical protein Tb927.11.6010 (17.9 kDa), this one only found in Trypanosoma
species [68]. The three hypothetical proteins were originally named according to their predicted
molecular weight, however, this nomenclature may cause confusion when comparing orthologs varying
in size between different species. Therefore, we opted to rename them here, so that the first protein,
Tb927.11.6720, will be called TbG1-IP (TbEIF4G1 Interacting Protein) as it binds the TbEIF4E5 complex
through TbEIF4G1, while Tb927.11.350 will be named as TbG1-IP2 and Tb927.11.6010 as TbG2-IP.
TbG1-IP is a large protein with two distinct domains, guanylyltransferase and methyltransferase,
both found in proteins involved in cap addition and modification during mRNA maturation [107],
and not yet seen or expected to be present in a cytoplasmic protein involved with translation
initiation factors. TbG2-IP is a putative RNA binding protein having two distinct domains
associated with RNA binding. Yeast two-hybrid assays have defined that TbG1-IP binds directly to
TbEIF4G1, and mass spectrometry assays of the TbG1-IP purified complex have shown that TbEIF4E5,
TbEIF4G1, and TbG1-IP2 interact in the absence of the 14-3-3 homolog [68]. The 14-3-3 proteins
are phosphoserine/phosphothreonine-binding proteins that bind to a multitude of functionally
diverse signaling factors and regulate protein–protein interactions [108,109]. Its absence from the
TbEIF4E5–TbEIF4G1–TbG1-IP–TbG1-IP2 complex might imply a dynamic exchange between two
complexes based on the TbEIF4E5–TbEIF4G1 interaction. The first complex would include TbG1-IP
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in the absence of the 14-3-3 homolog, while the second would have the 14-3-3 protein replacing
TbG1-IP [68] (Figure 6).
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Figure 6. Schematic representation of the eIF4F-like complexes formed by EIF4E5. One eIF4F-like
complex performed by EIF4E5 is composed by its interaction with EIF4G1, that binds to the
guanylyltransferase/methyltransferase domain-containing protein G1-IP (which seems to be regulated by
a 14-3-3 protein homolog) and G1-IP2, an RNA binding protein. The second EIF4E5 complex is composed
by its interaction with EIF4G2, which also binds to a protein of unknown function called here G2-IP.
3.3.3. EIF4E6 Binding Partners
The TbEIF4E6 yeast two-hybrid assays revealed a novel direct interaction with the last eIF4G
homolog, TbEIF4G5. Again, the interaction was specific, since no other eIF4E homolog bound to
TbEIF4G5, while no interaction between TbEIF4E6 and the remaining eIF4Gs was seen. Likewise,
mass spectrometry analysis confirmed that TbEIF4E6 associates in vivo with TbEIF4G5, and also forms
a novel complex that includes one more hypothetical protein, Tb927.11.14590 (70.3 kDa), that binds
directly to TbEIF4G5, named TbG5-IP [96] (Figure 7). Curiously, TbG5-IP also has distinct domains
seen in cap forming enzymes, a nucleoside triphosphate (NTP) hydrolase and a guanylyltransferase
domain [107]. The presence of proteins with cap generating domains interacting with homologs of
translation initiation factors is unprecedented, and raises questions regarding likely functions for
the EIF4E5 and EIF4E6 based complexes. Noteworthy is the fact that both eIF4E homologs and the
partners having guanylyltransferase domains would be expected to share the same substrate.
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3.3.4. EIF4E5 and EIF4E6 Knockdown Effects and Putative Roles
Targeted, RNAi mediated, knockdown experiments have indicated that neither TbEIF4E5 nor
TbEIF4E6 are essential for cell viability, cell division, or seem to be required for general translation in
procyclic cells [68,96]. These results have been, in part, contradicted by high throughput RNAi assays,
showing an abnormal growth effect after TbEIF4E5 knockdown, while TbEIF4E6 depletion led to a
significant loss of fitness in procyclic, bloodstream, and differentiating forms [91]. The inability to
generate double knockout cell lines for either protein may also be an indication that, in fact, both are
essential proteins [68,96]. The targeted TbEIF4E5 knockdown did induce an impairment of cellular
motility or swimming, inducing a “settling” phenotype in liquid media [68], a phenomena also observed
after knockdown of its putative partners, the 14-3-3 proteins [110]. Related to this, the TbEIF4E5
depletion also interfered with the social motility (SoMo) effect, observed when T. brucei cells are grown
in semisolid agar plates [68]. In tethering assays, the EIF4E5 partners TbEIF4G1, TbEIF4G2, and TbG2-IP
have behaved as activators of mRNA translation or stability [92,93]. In agreement with the similarities
in complex formation and binding partners, the TbEIF4E6 RNAi experiments also implied that both
TbEIF4E5 and TbEIF4E6 are related in function. Despite the absence of any changes induced by its
depletion on apparent motility, and the lack of the “settling” phenotype observed after the TbEIF4E5
RNAi, the TbEIF4E6 knockdown also interfered with the SoMo effect in cells grown in agar plates.
It also caused an unusual detachment of the flagellar in cells submitted to mild centrifugation, indicating
an impact on the flagellar attachment strength [96]. Overall, the results described so far for TbEIF4E5
and TbEIF4E6 indicate that both are indeed required for efficient cell growth, and that they may act
upon the regulation of the metabolism of specific mRNAs, perhaps as part of one or more regulons.
These would likely be associated somehow with cellular motility and/or flagellar attachment.
4. Concluding Remarks
In this review, the basic properties and the knowledge generated during the last two decades on
the six eIF4Es, the cytoplasmic cap binding proteins, from trypanosomatids, has been reviewed with
the focus on evaluating possible roles during translation initiation or its control. The uniqueness of the
trypanosomatid system can be highlighted by the identification of multiple eIF4F-like complexes, having
different eIF4E (six) and eIF4G (five) subunits, as well as novel binding partners with roles yet to be
properly defined. It seems plausible to speculate that, in the absence of transcriptional control, a system
of multiple eIF4F-like complexes has evolved in order to maximize the control of the fate of different
classes of mRNA regulons. This system could then play a role in cell cycle, differentiation and adaptation
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to environmental changes, such as those observed within the parasites’ different hosts. It is possible,
then, to suppose that the evolution of the translation initiation apparatus in trypanosomatids would
reflect an adaptation to parasitism on vertebrate hosts. This is unlikely, however, since all Leishmania
and Trypanosoma eIF4Es and partner proteins are found in monoxenous trypanosomatids, which are
mostly exclusive to insects, and also in Phytomonas species, plant parasites [5]. The multiple eIF4Es and
eIF4F-like complexes are unlikely to be related to parasitism, since most of the described trypanosomatid
eIF4Es and their partners are found in the related free-living kinetoplastid Bodo saltans [2]. Transition
from a free-living bacteriovorous lifestyle to parasitic life was followed by significant phenotypic
transformations that optimized basic genome functions, re-arranging, and removing redundant (or no
longer needed) metabolic pathways [4,111]. In this scenario, the conservation of translation initiation
factors during the transition to parasitism in Kinetoplastida denotes an ancient, complex, and unique
system that may be required for the control of gene expression in organisms lacking most known
mechanisms regulating mRNA synthesis. The multitude of eIF4Es and associated complexes, whose
functions are still not fully understood, are thus undoubtedly critical elements for the survival of these
pathogens that need to be investigated further.
Among all eIF4E homologs, a direct involvement by EIF4E1 and EIF4E2 during translation
initiation is unlikely for several reasons. The lack of eIF4G partners for either protein and their
absence from a true eIF4F complex rule out a role in general translation. Furthermore, their reduced
abundance, especially for EIF4E2, make them unlikely to be present in levels sufficient to support protein
synthesis in large scale [69,75]. Although LmEIF4E1 was proposed to be responsible for translation
initiation in axenic amastigotes in Leishmania, based on data from L. amazonensis where LaEIF4E4
was missing [87], no further direct evidence for a role in translation was reported to date, and in
L. infantum, sufficient levels of LiEIF4E4 were detected in amastigotes [94]. The fact that TbEIF4E1 does
not seem to be essential for cell survival in T. brucei, with a minor effect only in bloodstream forms after
knockdown [75], also suggest other functions. Indeed, the data from tethering experiments indicated
a major suppression effect of TbEIF4E1, and its identified partner 4E-IP [92,93] on mRNA translation.
Additionally, its partial localization to P-bodies-like granules under normal growth conditions [72]
also points to a possible role repressing the translation of selected mRNAs, similar to what has been
described for metazoans 4EHP [58,112]. This activity could be enhanced under stress conditions that
induce translation shutdown, and relocation of the translation machinery to stress granules. As EIF4E2
shares several features in common with EIF4E1, although it has not yet been shown to be able to repress
translation, it may also act as a regulator of translation acting upon selected mRNA populations.
A role for LmEIF4E3 during translation initiation has been previously discarded in Leishmania,
based on a lack of co-migration with LmEIF4G4 in sucrose gradient and to its presence, without
LmEIF4G4, in stress granules. These properties were postulated as indicative of roles in mRNA storage
or degradation [95]. However, TbEIF4E3 participation in stress granules was considered minor in
starvation stress granules in T. brucei [72], and both TbEIF4E3 and TbEIF4E4 and their partners were
found in polysomes from bloodstream cells, although TbEIF4E4 was more abundant [99]. That the
presence in stress granules cannot be considered a valid argument to rule out a role in translation is
highlighted by the fact that human eIF4E1, the prototype cap binding protein required for translation
initiation factor, is also found localized to both stress granules and P-bodies [113]. Furthermore, recent
work has shown that almost all T. brucei eIF4E and eIF4G homologs were identified as part of stress
granules during starvation [114]. TbEIF4E1 seems more suitable as a translation repressor [93], since it
is localized to stress granules even under optimal growth conditions, and has been shown to co-localize
with DHH1 [72], an ATP-dependent RNA helicase involved in mRNA turnover and decapping [115].
Another argument against a role for EIF4E3 during translation initiation is the fact that LmEIF4E3 does
not bind efficiently to the m7GTP or cap4 structures [79]. This is also debatable, since the data was
produced through in vitro studies and may not reflect what is happens in vivo, especially considering
that TbEIF4E3 can be found bound to polysomal mRNAs [93]. Perhaps additional conformation
changes are necessary to enhance EIF4E3 affinity to mRNAs in vivo, or it may be required to be part
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of a complex, perhaps with EIF4G4, to somehow compensate its lower affinity for the cap structure.
Nevertheless, its presence in levels far above those observed for its partner EIF4G4, in contrast to
EIF4E4 and EIF4G3 which are found with similar abundances in T. brucei at least [75,88], does suggest
roles other than as part of an eIF4F-like complex. More data are needed to explain the questions raised.
The scenario created by the available data indicates two major complexes, based on EIF4E3 and
EIF4E4, performing eIF4F related functions during translation initiation in trypanosomatids. Although
all analyzed eIF4E from Leishmania and Trypanosoma are significantly less abundant than yeast eIF4E,
their levels might be adequate within a scenario of multiple active eIF4F complexes and in the absence
of a 4E-BP like protein, such as the yeast p20 [75,116]. EIF4E3 and EIF4E4 are the most abundant of the
trypanosomatid eIF4Es and even though EIF4E3 is the only homologue confirmed to be essential in
both insect and vertebrate life stages in T. brucei [75], recent data from Leishmania EIF4E4 also confirms
its requirement for cell survival [94]. In addition, the fact that both proteins are present in polysomes
and are active stimulators of translation is a strong indication for a involvement in general translation
initiation [92,93,99]. Significant properties shared in common by both EIF4E3 and EIF4E4, such as
their structure, ability to bind to related eIF4G homologs and subcellular localization reinforce the
possibility that both can perform bona fide eIF4E roles. Specific features, however, may indicate
different requirements regarding mRNA recognition, leading to the binding to different mRNA targets.
The third set of trypanosomatid eIF4Es, containing EIF4E5 and EIF4E6, is characterized by unusual
eIF4F-like complexes, which associate eIF4E and eIF4G homologs with proteins having domains found
in enzymes responsible for mRNA cap addition and methylation [107]. Although neither EIF4E5
nor EIF4E6 are likely to play roles in general translation, mainly due to their low abundance and
to the fact that their knockdown did not affect translation rates, they might be required to regulate
translation of specific mRNA subsets. Their absence then would trigger the impairment in cell motility
and structural abnormalities [68,96]. A major aspect is their involvement with putative cap-generating
proteins. During the cap4 synthesis in trypanosomatids, it is known that the enzyme TbCgm1 is
responsible to add the cap0 structure to the 5′ end of the precursor SL RNA [117,118]. Subsequent
2′-O-methylations are performed by the methyltransferases TbMTr1 and TbMTr2 for the first two
nucleotides, while the third and fourth methylations are made by TbMTr3 [119,120]. All four enzymes
localize to the nucleoplasm, compatible with their activities targeting their newly transcribed SL
RNA substrate prior to the nuclear trans-splicing event. TbG1-IP is related to TbCgm1 in that both
have guanylyltransferase and methyltransferase domains[96], although the cytoplasm association
of TbG1-IP with the TbEIF4E5–TbEIF4G1 complex would rule out any role targeting the precursor
SL RNA. Furthermore, a novel cytoplasmic capping activity has been recently described associated
with the enzyme TbCe1. This has been proposed to be part of a novel pathway targeting mRNAs
that have undergone decapping in the cytoplasm, but, upon selective recapping by TbCe1, can be
reactivated and restored to the pool of translatable mRNAs [121]. Remarkably, TbCe1 is similar in
structure to TbG5-IP, part of the TbEIF4E6–TbEIF4G5 complex [96]. It is possible, then, that both
EIF4E5 and EIF4E6 based complexes could be part of novel pathways regulating mRNA translation
through selective decapping and recapping within the cytoplasm.
Altogether, the progress achieved on the study of the eIF4E initiation factors and translation
in general in trypanosomatids has raised more questions than it has solved. So far, the picture that
emerges is a dynamic one with the multiple homologs acting as part of different complexes targeting
multiple steps required for translation to proceed efficiently (summarized in Figure 8). A complex
selection process may determine which mRNA associates with which complex. This is likely to require
the participation of many of the multitude of RNA binding proteins and others which have relevant
roles as modulators of trypanosomatid gene expression [122–124]. Some important questions remain
to be answered, such as what are the targets recognized by each eIF4F(-like) complex [9], which if
any of these complexes play roles during cell differentiation and how their activities are regulated?
The last question may also help clarify what aspects are common, and which are unique to the distinct
life cycle of parasitic trypanosomatids [125,126]. The full picture of the translation initiation system
Pathogens 2017, 6, 55 19 of 25
in trypanosomatids seems to still be far way from being understood. Hence, future approaches are
needed to elucidate these questions and others in order to define specific roles for each eIF4E homolog
in mRNA metabolism as well as translation, contributing to the understanding of the biology of these
impressive organisms that seem to be specialized in doing things their own way.
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